AgPlus Diagnostics Ltd. has developed a rapid, handheld, low-cost diagnostic device that will deliver quantitative results within 10 minutes. Designed to work in both clinical and non-clinical settings, it uses a patented electrochemical immunoassay in a microfluidic chip to detect the test substance, combined with a read-out from charged silver nanoparticles, which increase the sensitivity of the test and allow the use of smaller samples than other diagnostic systems.

AgPlus Diagnostics Ltd. has developed a rapid, handheld, low-cost diagnostic device designed to deliver quantitative results within 10 minutes. Designed to work in both clinical and non-clinical settings, it uses a patented electrochemical immunoassay in a microfluidic chip to detect the test substance, combined with a read-out from charged silver nanoparticles, which increase the sensitivity of the test and allow the use of smaller samples than other diagnostic systems.

START-UP’s monthly comprehensive review of emerging life science companies that have received venture funding during the month, including companies within the in vitro diagnostics, pharmaceuticals, research/analytical equipment & supplies, and medical device sectors.

A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.